[Association of tow thrombotic risk factors: factor V Leiden and hyperhomocysteinemia. A case report].
The identification of constitutional and/or acquired risk factor is of major importance in the treatment of thromboembolic disease in young people; it contributes to evaluate the risk of recurrence and to define the period of oral prophylactic anticoagulant treatment. Several congenital or acquired abnormalities of haemostasis are actually defined. In this paper, we report the case of a 34-year-old man who developed a deep venous thrombosis, five months before the diagnosis of megaloblastic anemia, probably due to pernicious anemia. The thrombosis was partially explained by the acquired hyperhomocysteinemia induced by vitamin B12 deficiency. Moreover, activated protein C resistance due to factor V Leiden, was revealed in our patient. This latter improved under anticoagulant treatment combined with vitamin B12. Combination in one individual, of different risk factors predisposing to inherited and/or acquired thrombophilia, results in increased risk for thrombo-embolic disease, suggesting synergic interaction between these factors.
Znazen
R
R
Laboratoire d'hématologie, banque du sang, hôpital Charles-Nicolle, Bab-Bnet boulevard 9 avril, Tunis 1006, Tunisie. rajaznazen@yahoo.fr
Guermazi
S
S
Karoui
M
M
D000328:Adult; D000749:Anemia, Megaloblastic / Q000175:diagnosis; D005165:Factor V / Q000235:genetics*; D006801:Humans; D020138:Hyperhomocysteinemia / Q000150:complications*; D008297:Male; D012307:Risk Factors; D013927:Thrombosis / Q000453:epidemiology* / Q000235:genetics; D014806:Vitamin B 12 Deficiency
C095381:factor V Leiden; D005165:Factor V